Renato Maserati - Concepedia

Author

Renato Maserati

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

Maserati R, Maserati Renato, P. Caramello, P. Villani, R Maserati, R. Caldarelli-Stefano, R. MASERATI, R. Maserati, Renato Maserati

157

Publications

2.7K

Citations

H-Index

115

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Fondazione University of Pavia University of Milan Luigi Sacco Hospital

About

Renato Maserati is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	39	1.4K
2	Health Sciences	6	6	154
3	Public Health	6	6	304
4	Natural Sciences	1	1	63
5	Nursing	1	1	31

Renato Maserati

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit Marta Colaneri, Elena Seminari, Stefano Novati, Clinical Microbiology and Infection Virus ViabilityRna ContaminationRespiratory DiseasesRespiratory InfectionVirology	2020	147
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors☆☆☆★ Elena Seminari, Angelo Pan, Giuseppe Voltini, Atherosclerosis ThrombosisVascular DiseaseCardiovascular DiseaseCarotid UltrasonographyVascular Imaging	2002	126
Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy Paolo Maggi, Antonio Lillo, Francesco Perilli, AIDS	2004	95
Rhodococcus equi Infection in HIV-positive Subjects: A Retrospective Analysis of 24 Cases M. Arlotti, G. Zoboli, Gianluigi Moscatelli, Scandinavian Journal of Infectious Diseases AntibioticsClinical Infectious DiseaseR. Equi InfectionR. Equi PneumoniaRare Infection	1996	80
Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial Francesco Mazzotta, Sergio Lo Caputo, Carlo Torti, JAIDS Journal of Acquired Immune Deficiency Syndromes 48-Week Follow-upImmunologyVirtual PhenotypePharmacotherapyImmunotherapy	2003	63
Antiretrovirals: Simultaneous Determination of Five Protease Inhibitors and Three Nonnucleoside Transcriptase Inhibitors in Human Plasma by a Rapid High-Performance Liquid Chromatography–Mass Spectrometry Assay P. Villani, Marina Feroggio, Luca Gianelli, Therapeutic Drug Monitoring Mass Spectrometry DetectionAntiviral DrugMedicinal ChemistryGas ChromatographyBioanalysis	2001	63
Virological and Immunological Responses to a Once-a-Day Antiretroviral Regimen with Didanosine, Lamivudine and Efavirenz Franco Maggiolo, Marco Migliorino, Renato Maserati, Antiviral Therapy ImmunodeficienciesImmunologyPharmacotherapyAntiviral DrugHiv/aids Counselling	2002	63
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS Fausto de Lalla, Renato Maserati, Paolo Scarpellini, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesAntibioticsNegative Blood CulturesClinical Infection	1992	58
Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts Carlo Torti, Giuseppe Lapadula, Andrea Antinori, Infection Cardiovascular DiseaseMaster CohortsPatient SafetyAtazanavir TreatmentMedicine	2009	53
Clinical Pharmacokinetics of Nelfinavir and Its Metabolite M8 in Human Immunodeficiency Virus (HIV)-Positive and HIV-Hepatitis C Virus-Coinfected Subjects Mario Regazzi, Renato Maserati, P. Villani, Antimicrobial Agents and Chemotherapy	2005	52

Page 1